Top 10 Spatial Biology Companies
Federal policy turmoil helps deflate revenues for four of the top five publicly traded instrument developers, though private companies keep raising capital as investor interest grows.
Spatial Companies: Up & Comers 2026
Here are 10 “Up & Comers” spatial biology companies that are not large enough to be ranked as public or private companies, but warrant mention based on recent financings, collaborations, new products, attention in peer-reviewed publications, and other developments.
Top 10 Contract Development and Manufacturing Organizations 2026
Alex Philippidis analyzes the top CDMOs this year, noting a bright future as biopharma is expected to increase their reliance on CDMOs in coming years despite rising costs for their services. Which companies made the top 10 list? Check out the list to find out.
GEN Digital Edition
Access the latest issue of GEN and browse the archive of back issues when you subscribe to our digital edition.
Latest IssueSingle-Cell Multiomics: Phenotypic Plasticity in Colorectal Cancer Metastasis
In TOMORROW’s GEN webinar, Mirjana Efremova, PhD (Queen Mary University of London) will show how these technologies can be used to analyze primary and liver-metastatic CRC patient samples to reveal cancer cell states.
Mirjana Efremova, PhD
Senior Lecturer
Queen Mary University of London
The Aging Proteome: Clocks, Cohorts, and Clinical Trials
Perfusion-Based mAb Production at 250 mL Scale Using ATF Technology
The Organoid Odyssey: A Glimpse Into the Past, Present, and Future of hPSC-Derived 3D Models
Downstream Processing: Purifying Complex Antibody Therapeutics When Target Molecules Misbehave
Podcast
Touching Base
Touching Base is the dynamic podcast series from the editors of GEN. Each episode features a rotating case of senior editors—including John Sterling, Kevin Davies, Julianna LeMieux, Alex Phillippidis, Uduak Thomas, Corinna Singleman, and Fay Lin—who delve into emerging stories, exchange ideas, and debate the latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what’s now and next. Start listening today!
Stay up to date with the lasted episodes of Touching Base by subscribing to the GEN Podcast Newsletter
Beyond Amyloid and Tau: Alzheimer’s Drug Developer Sees Early Clinical Success for Immunotherapy-Based Approach
StockWatch: Amid Nvidia Turmoil, What Happens to Its Life Sciences Collaborations?
